Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-country, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of STA363 at Two Concentrations (60 mg/mL and 120 mg/mL) Compared to Placebo in Patients With Chronic Discogenic Low Back Pain

NCT04673461 is registered in ClinicalTrials.gov with Stayble Therapeutics as lead sponsor.

NCT NCT04673461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04673461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-country, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of STA363 at Two Concentrations (60 mg/mL and 120 mg/mL) Compared to Placebo in Patients With Chronic Discogenic Low Back Pain
Lead sponsor
Stayble Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2020
Completion date
October 31, 2023
Enrollment
110 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

discogenic pain